Fig. 5
From: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
Therapeutic potential of MSCs and their secretome for treating OA. Rendering literature, MSCs can be isolated from several sources ranging from bone marrow to endometrium and be injected into OA patients via the intra-articular route to induce encouraging outcomes. Mesenchymal stem/stromal cell (MSC); osteoarthritis (OA); matrix metalloproteinase (MMPs); fibroblast-like synoviocytes (FLS)